Table 2.

Effect of prognostic factors on complete response rate.

Prognostic Factor	No. of Patients	No. of Clinical Trials	Response Rate	p-Value
			Mean % [95% CI]
Age:				0.7743
$\le$65	483	12	50.7% [39.1–62.3]
>65	180	5	52.6% [24.0–81.1]
Lymphodepletion:				0.4737
Yes	835	12	57.1% [46.9–67.4]
No	13	3	42.9% [0–100]
CAR-T cells infused:				0.2043
$\le$1 × 107/kg	442	12	58.5% [47.0–70.0]
>1 × 107/kg	35	5	43.4% [5.8–81.0]
Cancer type:
B-ALL	184	5	72.3% [60.6–84.1]
DLBCL	490	9	41.4% [32.6–50.2]
FL	49	5	52.5% [30.2–74.7]
MCL	73	3	22.2% [0–100]